Login

ANTARES PHARMA, INC. SEC Filings

Filed On Filing
10 Feb 2023 SC 13G/A
03 Jun 2022 15-12B
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
31 May 2022 EFFECT
26 May 2022 Form 4: Richardson Peter C, See Remarks

Returned 50,613 shares to the issuer ($283K) · Disposed of 128,216 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Roche Robert P Jr, Director

Returned 167,817 shares to the issuer ($940K) · Disposed of 641,708 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Gueth Anton, Director

Returned 467,577 shares to the issuer ($2.62M) · Disposed of 621,708 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Smith Karen L., Director

Returned 79,645 shares to the issuer ($446K) · Disposed of 173,517 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Jacob Leonard S, Director

Returned 170,575 shares to the issuer ($955K) · Disposed of 1,147,882 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Graham Peter J, See Remarks

Returned 740,843 shares to the issuer ($4.15M) · Disposed of 1,321,433 Stock Option (right to buy) (Disposition to Issuer)

26 May 2022 Form 4: Garrity Thomas J, Director

Returned 249,858 shares to the issuer ($1.4M) · Disposed of 471,708 Stock Option (right to buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support